UNICYCIVE THERAPEUTICS, INC. Lessee, Operating Lease, Liability, Undiscounted Excess Amount
UNICYCIVE THERAPEUTICS, INC. (UNCY) had Lessee, Operating Lease, Liability, Undiscounted Excess Amount of $29.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Notes › Leases
us-gaap:LesseeOperatingLeaseLiabilityUndiscountedExcessAmount · last filed 2026-08-12
- 2026-06-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $29.00K.
- 2026-03-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $44.00K.
- 2025-12-31: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $1.00K.
- 2025-09-30: Lessee, Operating Lease, Liability, Undiscounted Excess Amount $7.00K.
| Period end | Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
|---|---|
| 2026-06-30 | $29.00K 10-Q · filed 2026-08-12 |
| 2026-03-31 | $44.00K 10-Q · filed 2026-05-12 |
| 2025-12-31 | $1.00K 10-K · filed 2026-03-30 |
| 2025-09-30 | $7.00K 10-Q · filed 2025-11-12 |
| 2025-06-30 | $16.00K 10-Q · filed 2025-08-14 |
| 2025-03-31 | $29.00K 10-Q · filed 2025-05-14 |
| 2024-12-31 | $45.00K 10-K · filed 2025-03-31 |
| 2024-09-30 | $64.00K 10-Q · filed 2024-11-13 |
| 2024-06-30 | $59.00K 10-Q · filed 2024-08-14 |
| 2024-03-31 | $75.00K 10-Q · filed 2024-05-13 |
| 2023-12-31 | $94.00K 10-K · filed 2024-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |